Background. Nontyphoidal Salmonella is the leading cause of bacterial gastroenteritis in the United States. Meal replacement products containing raw and "superfood" ingredients have gained increasing popularity among consumers in recent years. In January 2016, we investigated a multistate outbreak of infections with a novel strain of Salmonella Virchow.
Salmonella enterica is a diverse pathogen with >2500 recognized serotypes, many animal and environmental reservoirs, and varying degrees of pathogenicity in human hosts [1, 2] . Burden estimates attribute 1 million foodborne illnesses to salmonellosis in the United States annually, and Salmonella is the leading cause of bacterial gastroenteritis [3] . Nontyphoidal S. enterica is the second most common cause of foodborne disease outbreaks in the United States, and poultry and fresh produce consumption are well-established outbreak vehicles [4, 5] . Low-moisture foods, including spices and seasonings; dried protein products such as dried egg or dried milk; and seeds have been increasingly implicated as the source of foodborne salmonellosis outbreaks [6] [7] [8] .
Raw food diets and consumption of "superfoods" have gained increasing interest among consumers in recent years. While there are no standard definitions or official guidelines to what companies can market as raw foods or superfoods, "raw" generally refers to ingredients or foods, including fruits, nuts, and sprouted seeds that are unprocessed and/or minimally cooked [9] . Some raw ingredients or foods might be heated, but often at temperatures that are not high enough to eliminate pathogenic microorganisms or to reduce the potential for foodborne illness. "Superfood" is a marketing term for nutrient-dense foods, such as chia seeds, quinoa, and blue-green algae, with purported health benefits [10] . We report on an investigation of a multistate outbreak of infections with a novel strain of Salmonella Virchow linked to an organic raw powdered meal replacement product sold nationwide.
METHODS

Detection of the Outbreak
On 11 January 2016, PulseNet, the national molecular subtyping network for foodborne disease surveillance [11] , detected a cluster of 6 Salmonella Virchow infections from 5 states with an indistinguishable pulsed-field gel electrophoresis (PFGE) pattern. This was a new pattern to the PulseNet database. An underlying assumption of PulseNet for multistate outbreak detection is that bacterial isolates with indistinguishable PFGE patterns are more likely to share a common source, especially if the PFGE pattern is novel or rare. The Centers for Disease Control and Prevention (CDC), local and state health departments, and the US Food and Drug Administration (FDA) initiated a multistate investigation of the outbreak to determine the source and prevent additional illnesses.
Case Definition and Case Finding
A case was defined as infection with the outbreak strain of Salmonella Virchow (PFGE XbaI pattern TDXX01.0219) in a person with illness onset dates, or isolation dates if illness onsets were unknown, from 5 December 2015 to 26 April 2016.
PulseNet was used to detect cases. Salmonella isolates from ill people were sent to PulseNet-affiliated public health laboratories for PFGE using standardized protocols [12] . In addition, PulseNet USA shared the PFGE pattern with PulseNet International, a global laboratory network dedicated to bacterial foodborne disease surveillance, comprised of the national, regional, and subregional laboratory networks of Africa, Asia Pacific, Canada, Europe, Latin America and the Caribbean, and the Middle East to identify possible cases outside the United States [13] .
Hypothesis Generation
To determine the source of the outbreak, state and local public health officials interviewed ill people with state-specific enteric disease questionnaires to identify common foods and other exposures occurring in the week preceding illness onset. CDC compared exposures commonly reported by ill people with responses from healthy people previously interviewed as part of the 2006-2007 FoodNet Population Survey. This survey asked people residing in the surveillance areas about various exposures, including foods consumed in the week before interview, and is representative of 15% of the US population [14] . After investigators identified a suspected food product, CDC developed a focused questionnaire to collect brand, flavor, and other detailed product and purchase information about the suspected food product and similar foods consumed in the week before illness onset. State and local public health officials used this questionnaire for subsequent interviews.
Traceback Investigation and Firm Inspections
Based on lot numbers, best-by dates, and other information about the suspected food product obtained during interviews with ill people, FDA conducted a traceback investigation to determine whether there was a common source of contamination in the production or distribution chain for the suspected product consumed by case patients. FDA inspected 2 facilities involved in the production of the suspected product to collect environmental samples and assess manufacturing practices. During the investigations of these facilities, FDA also collected samples of raw ingredients and unopened packages of retained finished product. In addition, FDA inspected a third facility that supplied ingredients for the suspected product and collected environmental and ingredient samples. All environmental, ingredient, and finished product samples collected during these inspections were sent to FDA laboratories and tested for the presence of Salmonella [15] .
Additional Product Testing
State departments of health and agriculture collected opened containers of the suspected food product from the homes of ill people and unopened containers from retail stores for pathogen testing in state laboratories. State and federal laboratories performed serotyping and subtyping by PFGE using standard PulseNet protocols on all Salmonella isolates identified [12] .
RESULTS
Description of the Outbreak
A total of 35 cases were identified from 24 states ( Figure 1) ; illness onset dates ranged from 5 December 2015 to 12 April 2016 ( Figure 2 ). The median age of ill people was 35 years (range, <1-84 years); 58% were female. Six of 27 (22%) ill people with available information were hospitalized, and no deaths were reported. No cases were identified outside the United States.
Hypothesis Generation
Review of 5 state-specific questionnaires available on 25 January 2016 revealed that 5 (100%) ill people reported eating leafy green vegetables and 4 (80%) ill people reported eating chicken. However, a variety of different types of chicken and leafy greens were reported. These food items were not reported significantly more frequently by ill people than healthy people in the FoodNet Population Survey. Three (60%) ill people reported consuming powdered supplements, but the type and brand of powdered supplement consumed was initially available for only 1 ill person from Minnesota. Oregon and Utah state health partners reinterviewed the other 2 ill people who reported consuming powdered supplements to obtain additional information about the products. All 3 ill people reported consuming the same brand of raw powdered meal replacement product (hereafter defined as "product A").
Based on this information, investigators developed a questionnaire focusing on powdered supplements and powdered meal replacements to collect detailed product and purchase information. On 29 January 2016, 8 of 8 (100%) ill people interviewed reported consuming product A in the week before becoming ill; of these, 6 provided product lot numbers and best-by dates. Three common lot numbers with the same best-by date of September 2017 were identified among the 6 ill people.
At the conclusion on the investigation, 31 of 33 (94%) ill people interviewed with the focused questionnaire reported consuming a powdered supplement or a powdered meal replacement product in the week before becoming ill; of these, 30 (97%) reported consuming product A. Detailed product information on lot numbers and flavors was available from 22 ill people. Seven lot numbers were identified, with the best-by dates of September 2017 and October 2017. Three of the 4 flavors of product A available for purchase were reported by ill people, with chocolate (n = 12) and vanilla (n = 9) most commonly reported.
Traceback Investigation and Firm Inspections
Product A is an organic, shelf-stable, powdered product intended to be rehydrated by the consumer to consume as a drinkable snack or meal replacement shake. It contains >40 raw organic ingredients, including plant-based proteins, seeds, sprouts, greens, fruits, and vegetables. It also contains live probiotics, 
During its traceback investigation, FDA determined that product A was blended and packaged by the manufacturer (company A) in 2 facilities in Utah, and then distributed nationally (Figure 3) . FDA inspected the blending and packaging facilities in early February 2016, and did not identify any production practices that might lead to contamination. Three pooled environmental samples (242 swabs total) collected from the blending and packaging facilities were cultured by FDA and did not yield Salmonella.
FDA also collected 16 samples of individual raw ingredients used to make product A. Two of these 16 samples yielded Salmonella: 1 sample of organic moringa leaf powder and 1 sample of spinach powder. The sample of organic moringa leaf powder yielded the outbreak strain of Salmonella Virchow. The sample also yielded Salmonella Zanzibar and Salmonella II 42:z29:-. The sample of spinach powder yielded Salmonella Enteritidis only. Neither of these 2 raw ingredients nor the finished product were heat-treated or otherwise treated with a processing step to eliminate bacterial pathogens before packaging.
The results of microbiological testing prompted further traceback investigations of both contaminated raw ingredients. Company A used the organic moringa leaf powder exclusively to manufacture product A. The organic moringa leaf powder was supplied by an exporter in South Africa (exporter A). The shipments of organic moringa leaf were imported via a company in Washington (importer A); the shipments went from exporter A in South Africa to a warehouse in the United States (warehouse A) and then were shipped to the manufacturing facilities in Utah. The investigation also identified that in September 2015, company A had reformulated product A to include moringa leaf powder in product A for the first time. Product A has a 2-year shelf life; thus, the best-by dates reported during this investigation correspond to the time that the formulation changed [16] .
Review of records indicated the contaminated spinach powder was supplied by a supplier in Illinois (supplier A). FDA inspected this facility and did not identify any production practices that might lead to contamination at the facility. FDA collected 1 pooled environmental sample (125 swabs total) and 14 samples of products available at the time of inspection, including spinach powder, for testing; none yielded Salmonella. Further investigation determined that product A packages containing the contaminated lot of spinach powder had not been distributed to retailers and thus would not have been available for purchase by consumers.
Additional Product Testing
State partners collected 7 open containers of leftover product A from the homes of ill people in 6 states. Testing isolated the outbreak strain of Salmonella Virchow from 3 opened containers of leftover product collected from the homes of ill people in Oklahoma, Utah, and Oregon. The leftover product from Utah also yielded Salmonella Zanzibar and Salmonella II 42:z29:-. The PFGE patterns of these 2 isolates were indistinguishable from those of the Salmonella isolated from a sample of organic moringa leaf powder collected by FDA at the blending facility. A query of the PulseNet database did not identify any human illnesses with Salmonella Zanzibar or Salmonella II 42:z29:-. Twelve unopened containers having the same lot numbers as those reported by ill people were collected from various retail stores in Minnesota, and testing did not yield Salmonella.
Public Health Action
Based on information from the epidemiologic investigation, on 29 January 2016, Company A voluntarily recalled 30 lots of product A with best-by dates of August 2017-October 2017. After isolating the outbreak strain of Salmonella Virchow from organic moringa leaf powder, the company expanded the recall on 12 February 2016, to include all lots containing this raw ingredient [16] . Company A also announced the removal of organic moringa leaf powder from all of its products.
On 24 February 2016, FDA detained an incoming shipment of organic moringa leaf powder from exporter A. On 16 March 2016, FDA placed exporter A on Import Alert 99-19 based on investigation findings showing that moringa leaf powder from exporter A was contaminated with Salmonella [17] . The import alert stipulated that exporter A was found to be in violation of FDA regulations, and that moringa leaf powder from exporter A may no longer be accepted into in the United States. The import alert also informed FDA field personnel that shipments of organic moringa leaf from this exporter may be detained until the exporter provides evidence that these products are not contaminated with Salmonella.
Throughout the investigation, CDC, FDA, and state partners issued public communications to inform consumers of the investigation findings, product recalls, and actions they could take to prevent illness. These communications included web announcements, social media messaging, and state and national media reports [18, 19] .
DISCUSSION
We describe a nationwide outbreak of Salmonella Virchow infections linked to a powdered meal replacement product made with organic, raw ingredients. Past illness outbreaks have been linked to dietary supplements or food supplements, including a 1966 salmonellosis outbreak linked to a food supplement that was served as a warm gruel in multiple institutions [20] [21] [22] [23] . This investigation identified a raw, reconstituted meal replacement shake as a novel vehicle causing a multistate salmonellosis outbreak. The strong epidemiologic signal of nearly all ill people consuming a rare product was supported by isolating the outbreak strain from the implicated food product and one of its raw ingredients. The outbreak investigation led to a nationwide recall of all product A lots containing the contaminated organic moringa leaf powder, which likely prevented additional illnesses.
Powdered products such as product A are shelf-stable foods with low water activity, also referred to as low-moisture foods. Salmonella is the most frequently implicated pathogen in reported enteric illness outbreaks linked to low-moisture foods [21, 24, 25] . In a recent review of worldwide low-moisture food outbreaks, Salmonella was found to have caused 45% of the outbreaks [6] . Additionally, Salmonella can survive in low-moisture foods such as black pepper, peanut butter, and powdered products for more than a year under normal storage conditions [26] [27] [28] . Although low-moisture foods do not normally support the growth of Salmonella, once contaminated, Salmonella can survive at levels sufficient to cause clinical illness if consumed, as demonstrated by this and other foodborne salmonellosis outbreaks linked to low-moisture foods. Some examples include a 2007 outbreak linked to a broccoli powder added to a vegetable-coated snack food, a 2008 outbreak linked to peanut butter and other peanut products, and a 2009 outbreak linked to black and red pepper used to coat dried salami [7, 24, 29] . Since Salmonella had the potential to survive in the contaminated product A for much of its 2-year shelf life, a prolonged outbreak with additional illnesses would likely have occurred without the recall.
Meal replacement products have grown in popularity in the United States with product sales increasing from $8.2 billion in 2011 to $10.7 billion in 2014 [30] . These products are marketed as weight loss aids, nutritional supplements, or convenience foods for consumers with busy lifestyles. Meal replacement products are sold in a variety of forms, including dry powders that are reconstituted as shakes, and can be made from raw organic plant-or animal-derived ingredients, often sourced from a global supply chain. When manufacturing processes lack controls to effectively reduce microbial burden, pathogen contamination of any ingredients could result in contamination of the final product, which might lead to human illnesses when consumed [28] .
Product A was marketed as a raw, organic, healthy meal replacement and shake, containing multiple superfoods and other nutritional benefits, such as a rich source of vitamins, minerals, protein, and antioxidants. Products marketed as superfoods and raw foods appear to be increasingly important vehicles for foodborne Salmonella outbreaks, which might coincide with the rise in the number of products available. Over the course of the year 2015, there was a 30% rise in superfood products in the United States [31] . As the popularity of these superfoods has increased, CDC and state health partners have identified foodborne outbreaks linked to them. For example, a 2014 outbreak involving multiple Salmonella serotypes was linked to raw sprouted chia powder in the United States and Canada [32, 33] . Another example is the 2015 outbreak of Salmonella Paratyphi B variant L(+) tartrate(+) infections linked to raw sprouted nut butter spreads [34] .
Although the ultimate cause of Product A contamination in this outbreak was not determined, isolating the Salmonella Virchow outbreak strain from the organic moringa leaf powder supports that this ingredient was likely the means by which product A became contaminated. This is further supported by the fact that company A started using moringa leaf powder from the implicated supplier shortly before the outbreak began [16] . Moringa leaf, which comes from the moringa tree (Moringa oleifera), grows throughout tropical and subtropical countries [35] . All parts of the moringa tree, including the leaves, immature pods, seeds, bark, and flowers, are widely used and reported to be highly nutritious and display a number of medicinal properties [35, 36] .
Application of a pathogen reduction treatment, such as heat pasteurization or irradiation, to low-moisture food products aims to reduce the risk of product contamination and foodborne illness [26] . During the production of product A, no pathogen reduction treatment was applied to any of the raw ingredients or the finished product before product A was distributed to consumers. This was an intentional practice by the manufacturer since it advertises health benefits attributed to the raw product. However, if a pathogen reduction step had been applied during the production of product A, it could have mitigated the risk.
This investigation identified a novel outbreak vehicle responsible for illness in 35 people in 24 states. It highlights the potential food safety risk carried by raw powdered ingredients that do not undergo a pathogen reduction step during their manufacture. This investigation also demonstrates the importance of close collaboration among state and federal public health investigators to resolve foodborne outbreaks quickly and decisively to prevent additional cases of illness, particularly when shelf-stable products are implicated. Finally, this outbreak emphasizes the complex nature of food safety when raw food products are not intended to be cooked by the consumer before use-for these types of products, food safety depends on both the careful manufacture and distribution of the final product as well as the use of ingredients that are free from contamination. 
